Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 8
Submit an article Journal homepage
481
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group

Seok Jin KimDivision of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Joon Ho MoonDepartment of Oncology/Hematology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea
,
Hawk KimDepartment of Hematology-Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
,
Jin Seok KimDivision of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
,
Yu Yan HwangDepartment of Medicine, Queen Mary Hospital, Hong Kong, China
,
Tanin IntragumtornchaiDivision of Hematology, Department of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
,
Surapol IssaragrisilDepartment of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
,
Jae Yong KwakDepartment of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea
,
Je Jung LeeDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea
,
Jong Ho WonDepartment of Internal Medicine, Soon Chun Hyang University College of Medicine, Seoul, Korea
,
Arry Harryanto ReksodiputroDivision of Hematology-Oncology, Department of Internal Medicine, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
,
Soon Thye LimDepartment of Medical Oncology, National Cancer Center Singapore, Singapore
,
Ann-Lii ChengDepartment of Oncology and Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
,
Won Seog KimDivision of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaCorrespondence[email protected]
&
Yok Lam KwongDepartment of Medicine, Queen Mary Hospital, Hong Kong, China
 show all
Pages 1515-1524 | Received 09 Nov 2011, Accepted 17 Jan 2012, Published online: 01 Mar 2012

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Antonio Riccardo Buonomo, Emanuela Zappulo, Giulio Viceconte, Riccardo Scotto, Guglielmo Borgia & Ivan Gentile. (2018) Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis. Expert Opinion on Drug Safety 17:7, pages 709-717.
Read now

Articles from other publishers (27)

Mihaela Andreescu. (2023) Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies. Life 13:6, pages 1272.
Crossref
Carol Y. M. Cheung, Rock Y. Y. Leung, Anthony Raymond Tam, Joycelyn P. Y. Sim & Yok-lam Kwong. (2023) Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia. Annals of Hematology 102:2, pages 483-485.
Crossref
Marija Cauchi, Mark Willis, Angela Andrews, Matthijs Backx, Wallace Brownlee, Helen L Ford, Bruno Gran, Stephen Jolles, Sian Price, Waqar Rashid, Klaus Schmierer & Emma C Tallantyre. (2022) Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline. Practical Neurology 22:5, pages 344-357.
Crossref
Asako Tagawa. (2022) Infectious issues of therapeutic monoclonal antibodies in multiple sclerosis and neuromyelitis optica spectrum disorders. Clinical and Experimental Neuroimmunology 13:3, pages 143-155.
Crossref
Mark Robbins & Karen Doucette. 2022. Infectious Complications in Biologic and Targeted Therapies. Infectious Complications in Biologic and Targeted Therapies 431 450 .
Tyler Ellis Smith & Ilya Kister. (2021) Infection Mitigation Strategies for Multiple Sclerosis Patients on Oral and Monoclonal Disease-Modifying Therapies. Current Neurology and Neuroscience Reports 21:7.
Crossref
Ioannis Kyriakidis, Eleni Vasileiou, Claudia Rossig, Emmanuel Roilides, Andreas H. Groll & Athanasios Tragiannidis. (2021) Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. Journal of Fungi 7:3, pages 186.
Crossref
Anat Zalmanovich, Ronen Ben-Ami, Galia Rahav, Danny Alon, Allon Moses, Karen Olshtain-Pops, Miriam Weinberger, Pnina Shitrit, Michal Katzir, Bat-Sheva Gottesman & Michal Chowers. (2020) Rituximab identified as an independent risk factor for severe PJP: A case-control study. PLOS ONE 15:9, pages e0239042.
Crossref
Yu Shi & Min Zheng. (2020) Hepatitis B virus persistence and reactivation. BMJ, pages m2200.
Crossref
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye & Michael Boyle. (2020) Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 33:3.
Crossref
Agnieszka Wójtowicz, Stéphanie Bibert, Patrick Taffé, Enos Bernasconi, Hansjakob Furrer, Huldrych F. Günthard, Matthias Hoffmann, Michael Osthoff, Matthias Cavassini & Pierre-Yves Bochud. (2019) IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients. AIDS 33:11, pages 1719-1727.
Crossref
David J Epstein, Jeffrey Dunn & Stan Deresinski. (2018) Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management. Open Forum Infectious Diseases 5:8.
Crossref
R.J. van de Peppel, L.G. Visser, O.M. Dekkers & M.G.J. de Boer. (2018) The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review. Journal of Infection 76:6, pages 550-562.
Crossref
Kwai Han Yoo, Hyewon Lee & Cheolwon Suh. (2018) Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial. International Journal of Hematology 107:4, pages 395-404.
Crossref
Liang-Kung Chen, Hidenori Arai, Liang-Yu Chen, Ming-Yueh Chou, Samsuridjal Djauzi, Birong Dong, Taro Kojima, Ki Tae Kwon, Hoe Nam Leong, Edward M. F. Leung, Chih-Kuang Liang, Xiaohong Liu, Dilip Mathai, Jiun Yit Pan, Li-Ning Peng, Eduardo Rommel S. Poblete, Philip J. H. Poi, Stewart Reid, Terapong Tantawichien & Chang Won Won. (2017) Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infectious Diseases 17:1.
Crossref
Bonnie Kho, Howard H. N. Wong, Chun-Fung Sin, Rock Y. Y. Leung & Yok-Lam Kwong. (2017) Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab. Annals of Hematology 96:12, pages 2121-2123.
Crossref
Ioannis Kyriakidis, Athanasios Tragiannidis, Ilse Zündorf & Andreas H. Groll. (2017) Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. Mycoses 60:8, pages 493-507.
Crossref
Catherine Cordonnier, Simone Cesaro, Georg Maschmeyer, Hermann Einsele, J. Peter Donnelly, Alexandre Alanio, Philippe M. Hauser, Katrien Lagrou, Willem J. G. Melchers, Jannik Helweg-Larsen, Olga Matos, Stéphane Bretagne & Johan Maertens. (2016) Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. Journal of Antimicrobial Chemotherapy 71:9, pages 2379-2385.
Crossref
Yasemin Oz, Muge Aslan, Filiz Aksit, Selma Metintas & Eren Gunduz. (2016) The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients. Mycoses 59:2, pages 86-92.
Crossref
Man Fai Law, Rita Ho, Carmen K M Cheung, Lydia H P Tam, Karen Ma, Kent C Y So, Bonaventure Ip, Jacqueline So, Jennifer Lai, Joyce Ng & Tommy H C Tam. (2016) Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy. World Journal of Gastroenterology 22:28, pages 6484.
Crossref
S.‐H. Choi, J.‐Y. Hwang, K.‐S. Park, Y. Kim, S.H. Lee, K.H. Yoo, E.‐S. Kang, J.‐H. Ahn, K.W. Sung, H.H. Koo & Y.‐J. Kim. (2014) The impact of drug‐resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL 97 and UL 54 gene mutations . Transplant Infectious Disease 16:6, pages 919-929.
Crossref
Yok-Lam Kwong. (2013) Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides. Annals of Hematology 93:4, pages 713-714.
Crossref
Brian A. Baldo. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 561 590 .
C. Roux, A. Thyss & M. Gari-Toussaint. (2013) Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia. Journal de Mycologie Médicale 23:4, pages 270-273.
Crossref
T. S. Y. Chan, Y.-Y. Hwang, H. Gill, W. W. W. Cheung, E. Tse, A. Y. H. Leung, C.-S. Chim, A. K. W. Lie & Y.-L. Kwong. (2013) Antifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospital. Internal Medicine Journal 43:5, pages 541-546.
Crossref
Cheolwon SuhWon Seog KimJin Seok KimByeong-Bae Park. (2013) Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working Party. Blood Research 48:3, pages 171.
Crossref
Raoul Herbrecht, Pierre Bories, Jean-Charles Moulin, Marie-Pierre Ledoux & Val?rie Letscher-Bru. (2012) Risk stratification for invasive aspergillosis in immunocompromised patients. Annals of the New York Academy of Sciences 1272:1, pages 23-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.